Electromed Posts 16th Straight Growth Quarter: Revenue +10.6%, EPS $0.32
ELMD sits 18% above its 52-week low of $23.01.
Summary
Electromed delivered its 16th consecutive quarter of year-over-year revenue and operating income growth, with Q1 FY2027 revenue of $18.7M (+10.6%) and diluted EPS of $0.32 (+29.3%). Gross margin hit 80.0%, and the company bought back $4.3M of stock while staying debt-free.
Key Events · Earnings and Guidance · ELMD
-
Q1 FY2027 Revenue Up 10.6%
Net revenues came in at $18.7M versus $16.9M a year ago, led by a 17.6% increase in the core homecare business to $17.5M.
-
Operating Income Jumps 30.7%
Operating income rose to $3.5M, or 18.7% of net revenues, from $2.7M and 15.8%; gross margin expanded to 80.0% from 78.1%.
-
EPS $0.32, Up 29.3%
Net income was $2.8M, or $0.32 per diluted share, versus $2.1M, or $0.25, in the prior-year quarter.
-
Non-Homecare Channels Weaken
Hospital revenue fell 31.6% to $0.7M and homecare distributor revenue fell 55.9% to $0.4M, leaving total non-homecare revenue at $1.2M.
Analysis · ELMD · Industrial Applications And Services
The growth engine is still running: fiscal Q1 2027 revenue rose 10.6% to $18.7M, operating income climbed 30.7% to $3.5M, and diluted EPS advanced 29.3% to $0.32. Margins are the real substance here, with gross margin reaching 80.0% and operating margin 18.7%, both up sharply, so profit is growing roughly three times faster than sales. Outside the core, the picture is softer: hospital revenue fell 31.6% and homecare distributor revenue fell 55.9%, meaning essentially all growth came from the direct homecare channel, which rose 17.6% to $17.5M on 63 field sales reps. Management also spent $4.3M buying back stock during the quarter, which is why cash dropped $4.6M to $15.9M despite positive operating cash flow; the company remains debt-free with $44.9M of working capital. At $27.18 today, the $0.32 quarterly EPS annualizes to roughly $1.28, so the market is paying a premium multiple that leaves little room for the non-homecare weakness to spread.
How filings like this one have moved
In the 30 days to Nov 11, 2026, 36.6% of the 3434 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, ELMD was trading at $27.18 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $225.2M. The 52-week trading range was $23.01 to $47.40. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.